Trevi Therapeutics, Inc. - Common Stock — キャッシュフロー (NASDAQ:TRVI) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -29 M-28.95 M-28.18 M-31.71 M-38.26 M-42.09 M -45.3 M 投資活動によるキャッシュフロー -32 K-32 K-107.37 M59.43 M-21.53 M-94.11 M -67.19 M 財務活動によるキャッシュフロー 16.72 M20.77 M111.31 M-7.91 M61.48 M121.01 M 112.53 M フリーキャッシュフロー -29 M-28.95 M-28.18 M-31.71 M-38.26 M-42.1 M -45.41 M

ニュース

Trevi Therapeutics, Inc. (TRVI) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript

Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call Transcript

Trevi Therapeutics: Late-Stage Transition Meets Execution Risk (NASDAQ:TRVI)

What's Going On With Trevi Therapeutics Stock? - Trevi Therapeutics (NASDAQ:TRVI)

Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call Transcript

Zacks.com featured highlights include Trevi, Metalla Royalty & Streaming and Vermilion

Trevi Therapeutics株、第3相試験計画でOppenheimerが評価

Trevi Therapeutics stock gets Oppenheimer nod on Phase 3 plans

Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March

Trevi、IPF患者の慢性咳嗽治療で2つの第3相試験を計画

Trevi plans two phase 3 trials for chronic cough treatment in IPF

Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?